Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China flag China · Delayed Price · Currency is CNY
26.48
-0.03 (-0.11%)
At close: Feb 27, 2026

SHA:600196 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
65,06459,74961,59286,922113,862125,791
Market Cap Growth
14.71%-2.99%-29.14%-23.66%-9.48%93.27%
Enterprise Value
101,06790,78489,228110,109134,998147,717
Last Close Price
26.4824.5624.4633.9546.5451.04
PE Ratio
21.3921.5725.8223.3024.0834.34
Forward PE
35.7821.1521.4919.3620.4330.68
PS Ratio
1.651.461.491.982.924.15
PB Ratio
1.071.001.091.612.352.74
P/TBV Ratio
2.832.732.893.995.836.40
P/FCF Ratio
203.12894.58----
P/OCF Ratio
13.3513.3518.0420.6128.9248.76
PEG Ratio
-1.021.021.021.022.05
EV/Sales Ratio
2.562.212.152.513.464.87
EV/EBITDA Ratio
19.0816.4722.9819.8732.2736.18
EV/EBIT Ratio
41.1430.5375.3432.1953.2256.42
EV/FCF Ratio
315.511359.25----
Debt / Equity Ratio
0.600.600.620.560.530.52
Debt / EBITDA Ratio
6.936.078.445.255.865.63
Debt / FCF Ratio
114.65539.31----
Net Debt / Equity Ratio
0.380.330.340.240.230.26
Net Debt / EBITDA Ratio
4.763.615.012.352.602.94
Net Debt / FCF Ratio
72.49297.96-10.12-7.79-10.53-6.47
Asset Turnover
0.340.360.380.440.440.38
Inventory Turnover
2.912.903.013.773.823.03
Quick Ratio
0.660.680.730.780.750.71
Current Ratio
0.920.921.001.061.041.01
Return on Equity (ROE)
6.75%6.03%5.23%7.70%10.55%9.25%
Return on Assets (ROA)
1.32%1.61%0.67%2.13%1.79%2.05%
Return on Invested Capital (ROIC)
2.44%3.21%1.47%4.67%3.56%4.04%
Return on Capital Employed (ROCE)
3.00%3.70%1.50%4.60%4.00%4.50%
Earnings Yield
5.05%4.64%3.87%4.29%4.15%2.91%
FCF Yield
0.49%0.11%-3.12%-1.92%-0.91%-1.48%
Dividend Yield
1.21%1.30%1.10%1.24%1.20%0.84%
Payout Ratio
63.02%74.35%102.89%63.64%40.48%50.09%
Buyback Yield / Dilution
1.39%-0.02%-2.40%-1.74%--
Total Shareholder Return
2.60%1.28%-1.29%-0.50%1.20%0.84%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.